TuisNDOI • OTCMKTS
add
Endo Inc
Vorige sluiting
$24,00
Jaarwisseling
$23,00 - $29,75
Markkapitalisasie
1,83 mjd USD
Gemiddelde volume
23,53 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
OTCMKTS
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Jun. 2024info | J/J-verandering |
---|---|---|
Inkomste | 446,63 m | -18,33% |
Bedryfskoste | 152,88 m | -7,77% |
Netto inkomste | 6,38 mjd | 27 115,51% |
Netto winsgrens | 1,43 k | 33 191,38% |
Wins per aandeel | — | — |
EBITDA | 219,24 m | -24,25% |
Effektiewe belastingkoers | -0,22% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Jun. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 293,54 m | -66,10% |
Totale bates | 4,96 mjd | -8,55% |
Totale aanspreeklikheid | 3,12 mjd | -67,29% |
Totale ekwiteit | 1,83 mjd | — |
Uitstaande aandele | 76,40 m | — |
Prys om te bespreek | 1,00 | — |
Opbrengs op bates | 7,86% | — |
Opbrengs op kapitaal | 13,58% | — |
Kontantvloei
Netto kontantverandering
(USD) | Jun. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 6,38 mjd | 27 115,51% |
Kontant van bedrywe | -698,60 m | -648,70% |
Kontant van beleggings | -6,25 m | 40,69% |
Kontant van finansiering | 274,16 m | 279,95% |
Netto kontantverandering | -431,46 m | -1 131,80% |
Beskikbare kontantvloei | -264,84 m | -249,44% |
Meer oor
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system. Wikipedia
Gestig
1920
Hoofkwartier
Webwerf
Werknemers
2 995